Project: A rapid diagnostic test to predict heart failure after a myocardial infarction

Acronym HEARTLINC (Reference Number: 11020)
Duration 01/05/2017
Project Topic The consortium will develop an innovative in vitro diagnostic (IVD) test to assess the risk of developing heart failure (HF) after acute myocardial infarction (AMI). The test is based on a unique profile of long noncoding RNAs (lncRNA). In this project, the medical benefit of the IVD test will be validated in blood samples of European and Asian AMI patients. The HEARTLINC project will deliver an IVD test suitable for fast, multiplex and high throughput HF prediction.
Network Eurostars 2
Call Eurostars Cut-Off 6

Project partner

Number Name Role Country
1 Firalis SAS Coordinator France
2 QuantaMatrix Inc. Partner Korea, Republic of
3 SimplicityBio SA Partner Switzerland
4 Seoul National University Hospital Partner Korea, Republic of
5 Centre Hospitalier Universitaire de Toulouse Partner France